![](/img/cover-not-exists.png)
Optimal Tobramycin Dosage in Patients with Cystic Fibrosis – Evidence for Predictability Based on Previous Drug Monitoring
K. Bartel, T. Habash, S. Lugauer, H. Bärmeier, B. Böwing, M. Ünsal, C. Schoerner, U. HeiningerVolume:
27
Language:
english
Pages:
4
DOI:
10.1007/s150100050027
Date:
September, 1999
File:
PDF, 83 KB
english, 1999